1024免费一级欧美片在线观看_久久免费精品视频互動交流_国国产无套粉嫩白浆在线_饥渴难耐的浪荡艳妇_亚洲国产日韩一区在线_欧美激情性爱吧_精品人妻少妇av嫩草_嗯啊不要视频_另类欧美亚洲综合_网友自拍亚洲无码另类

杭州昊鑫生物科技股份有限公司
網(wǎng)站標(biāo)題
搜索

取消

清空記錄

歷史記錄

清空記錄

歷史記錄

清空記錄

歷史記錄

杭州昊鑫生物科技股份有限公司
    當(dāng)前位置:
  • 首頁(yè)>
  • 產(chǎn)品中心>
  • MCE>
  • Mitoquinone...

產(chǎn)品中心

Mitoquinone mesylate (米托蒽醌甲磺酸鹽)

分享到微信

×
Mitoquinone mesylate是一種基于TPP的線粒體靶向抗氧化劑,可防止氧化損傷。貨號(hào):HY-100116A ,CAS:845959-50-4
參數(shù)品牌:MCE
產(chǎn)品參數(shù)
品牌:MCE
型號(hào):HY-100116A
起訂量:1
規(guī)格::5mg
價(jià)格::¥1100
我知道了
在線客服
產(chǎn)品詳情

Mitoquinone mesylate (Synonyms: 米托蒽醌甲磺酸鹽)

Mitoquinone mesylate是一種基于TPP的線粒體靶向抗氧化劑,可防止氧化損傷。

生物活性

Mitoquinone mesylate is a TPP-based, mitochondrially targeted antioxidant in order to protect against oxidative damage[1].


體外研究(In Vitro)

Mitoquinone (MitoQ) is a mitochondria-targeted antioxidant.The optimal doses for Mitoquinone (MitoQ) and DecylTPP treatment are selected from dose-response experiments during 4-h cold storage (CS). The potential protective benefits of Mitoquinone treatment against CS injury are tested initially using MitoSOX Red, a mitochondrial-targeted fluorescent dye that measures mitochondrial superoxide generation. Normal rat kidney (NRK) cells exposed to CS result in a ~2-fold increase in fluorescence due to mitochondrial superoxide compared with untreated cells. Mitoquinone offers significant protection against CS-induced mitochondrial superoxide generation; whereas the control compound DecylTPP does not offer any protection. Mitoquinone treatment markedly decreases mitochondrial superoxide generation, whereas kidneys treated with DecylTPP have comparable levels of mitochondrial superoxide to kidneys exposed to CS alone[1].


體內(nèi)研究(In Vivo)

Mitoquinone (MitoQ) treatment significantly reduces pancreatic oedema and neutrophil infiltration. MitoQ dose-dependently increases serum amylase with an approximate doubling at the higher dose. MitoQ treatment nearly doubles lung MPO activity induced by Caerulein with a significant increase of serum IL-6 levels also evident at 10?mg/kg (dose 1)[2].


分子量:678.81


Formula:C38H47O7PS


CAS 號(hào):845959-50-4


中文名稱(chēng):米托蒽醌甲磺酸鹽;米拖蒽醌甲磺酸鹽


運(yùn)輸條件:Room temperature in continental US; may vary elsewhere.


儲(chǔ)存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


溶解性數(shù)據(jù)

DMSO : 50 mg/mL (73.66 mM; Need ultrasonic)

H2O : 8.33 mg/mL (12.27 mM; ultrasonic and warming and heat to 60°C)

配制儲(chǔ)備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM1.4732 mL7.3658 mL14.7317 mL
5 mM0.2946 mL1.4732 mL2.9463 mL
10 mM0.1473 mL0.7366 mL1.4732 mL
*

請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。

In Vivo:

以下溶解方案都請(qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:

——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 1.


    請(qǐng)依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (3.68 mM); Clear solution


  • 2.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: 2.5 mg/mL (3.68 mM); Suspended solution; Need ultrasonic


參考文獻(xiàn)



Mitoquinone mesylate (米托蒽醌甲磺酸鹽)

Mitoquinone mesylate (米托蒽醌甲磺酸鹽)

分享到微信

×
Mitoquinone mesylate是一種基于TPP的線粒體靶向抗氧化劑,可防止氧化損傷。貨號(hào):HY-100116A ,CAS:845959-50-4
品牌:MCE
型號(hào):HY-100116A
起訂量:1
規(guī)格::5mg
價(jià)格::¥1100
15906629305
在線客服
產(chǎn)品詳情

Mitoquinone mesylate (Synonyms: 米托蒽醌甲磺酸鹽)

Mitoquinone mesylate是一種基于TPP的線粒體靶向抗氧化劑,可防止氧化損傷。

生物活性

Mitoquinone mesylate is a TPP-based, mitochondrially targeted antioxidant in order to protect against oxidative damage[1].


體外研究(In Vitro)

Mitoquinone (MitoQ) is a mitochondria-targeted antioxidant.The optimal doses for Mitoquinone (MitoQ) and DecylTPP treatment are selected from dose-response experiments during 4-h cold storage (CS). The potential protective benefits of Mitoquinone treatment against CS injury are tested initially using MitoSOX Red, a mitochondrial-targeted fluorescent dye that measures mitochondrial superoxide generation. Normal rat kidney (NRK) cells exposed to CS result in a ~2-fold increase in fluorescence due to mitochondrial superoxide compared with untreated cells. Mitoquinone offers significant protection against CS-induced mitochondrial superoxide generation; whereas the control compound DecylTPP does not offer any protection. Mitoquinone treatment markedly decreases mitochondrial superoxide generation, whereas kidneys treated with DecylTPP have comparable levels of mitochondrial superoxide to kidneys exposed to CS alone[1].


體內(nèi)研究(In Vivo)

Mitoquinone (MitoQ) treatment significantly reduces pancreatic oedema and neutrophil infiltration. MitoQ dose-dependently increases serum amylase with an approximate doubling at the higher dose. MitoQ treatment nearly doubles lung MPO activity induced by Caerulein with a significant increase of serum IL-6 levels also evident at 10?mg/kg (dose 1)[2].


分子量:678.81


Formula:C38H47O7PS


CAS 號(hào):845959-50-4


中文名稱(chēng):米托蒽醌甲磺酸鹽;米拖蒽醌甲磺酸鹽


運(yùn)輸條件:Room temperature in continental US; may vary elsewhere.


儲(chǔ)存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


溶解性數(shù)據(jù)

DMSO : 50 mg/mL (73.66 mM; Need ultrasonic)

H2O : 8.33 mg/mL (12.27 mM; ultrasonic and warming and heat to 60°C)

配制儲(chǔ)備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM1.4732 mL7.3658 mL14.7317 mL
5 mM0.2946 mL1.4732 mL2.9463 mL
10 mM0.1473 mL0.7366 mL1.4732 mL
*

請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。

In Vivo:

以下溶解方案都請(qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:

——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 1.


    請(qǐng)依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (3.68 mM); Clear solution


  • 2.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: 2.5 mg/mL (3.68 mM); Suspended solution; Need ultrasonic


參考文獻(xiàn)



選擇區(qū)號(hào)